HealthQuill COVID-19
A recent spillover to mammals of H5N1 avian influenza needed to be “monitored closely” as the WHO readies vaccines and antivirals and urged governments to increase surveillance.
Climate Drugs Pharma

H5N1 influenza’s spread to mammals needs ‘close monitoring’

A recent spillover to mammals of H5N1 avian influenza needed to be “monitored closely” as the WHO readies vaccines and antivirals and urged.

Read More
BioNTech SE, an immunotherapy company, will invest $43 million in a new facility in Germany to make a vital ingredient for its mRNA drugs.
Drugs Pharma

BioNTech to invest $43 million in new mRNA facility

BioNTech SE, an immunotherapy company, will invest $43 million in a new facility in Germany to make a vital ingredient for its mRNA.

Read More
Stelis Biopharma, a division of India’s Strides Pharma Science, will become a full-fledged contract development and manufacturing firm and may list “near-term.
Drugs Health Pharma

Stelis Biopharma to be pure play CDMO firm, may list ‘near termâ€™ïżŒ

Stelis Biopharma, a division of India’s Strides Pharma Science, will become a full-fledged contract development and manufacturing firm and may list “near-term.

Read More
Glenmark Pharmaceuticals, an Indian global drug maker with a focus on dermatology, respiratory and oncology areas, forecasts lifting of China's COVID-19 curbs may ease disruptions in the supply chain situation.
Drugs Medical Pharma

China’s lifting of COVID-19 curbs to ease supply chain disruptions: Glenmark

Glenmark Pharmaceuticals, an Indian global drug maker with a focus on dermatology, respiratory and oncology areas, forecasts lifting of China's COVID-19 curbs may.

Read More
The U.S. plans to end COVID-19 emergency restrictions by May 11, according to a statement by the Office of Management and Budget.
Health Medical Pharma

U.S. to end Covid-19 curbs on May 11, migrant policy remains same

The U.S. plans to end COVID-19 emergency restrictions by May 11, according to a statement by the Office of Management and Budget.

Read More
Pfizer refuted allegations by Project Veritas, a media organization, in its ongoing COVID-19 vaccine work stating it has “not conducted gain-of-function” or “directed evolution research.”
Drugs Medical Pharma

No ‘directed evolution research’ in COVID-19 vaccine: Pfizer

Pfizer refuted allegations by Project Veritas, a media organization, in its ongoing COVID-19 vaccine work stating it has “not conducted gain-of-function” or “directed.

Read More
The number of people affected by neglected tropical diseases (NTDs) has fallen by 80 million between 2020 and 2021, a WHO report stated.
Drugs Health Pharma

NTD incidence fall by 80 million people, WHO chief calls for funds

The number of people affected by neglected tropical diseases (NTDs) has fallen by 80 million between 2020 and 2021, a WHO report stated.

Read More
The Covid-19 virus had claimed the lives of 170,000 people over the last eight weeks, after China lifted restrictions imposed during early stages of the pandemic, the WHO stated.
Health Medical Pharma

Massive spike in Covid-19 deaths over eight weeks: WHO

The Covid-19 virus had claimed the lives of 170,000 people over the last eight weeks, after China lifted restrictions imposed during early stages.

Read More
Roche, a Swiss multinational healthcare company, has unveiled a new test for targeting the fast-spreading XBB.1.5 Omicron sub-variant.
Drugs Medical Pharma

Roche unveils test to trace fast-spreading Omicron variantïżŒ

Roche, a Swiss multinational healthcare company, has unveiled a new test for targeting the fast-spreading XBB.1.5 Omicron sub-variant.

Read More
Bharat Biotech, an Indian maker of vaccines for infectious diseases, has rolled out the world's first nasal Covid-19 drops as a booster dose, according to a company statement.
Drugs Medical Pharma

India’s Bharat Biotech rolls out Covid-19 nasal drop vaccine

Bharat Biotech, an Indian maker of vaccines for infectious diseases, has rolled out the world's first nasal Covid-19 drops as a booster dose,.

Read More